AZIMILIDE
AZIMILIDE 物理性質
- 沸点 :
- 594.9±60.0 °C(Predicted)
- 比重(密度) :
- 1.32
- 貯蔵温度 :
- 2-8°C
- 溶解性:
- <4.58mg/mL in DMSO
- 外見 :
- Powder
- 酸解離定数(Pka):
- 7.72±0.10(Predicted)
安全性情報
- リスクと安全性に関する声明
- 危険有害性情報のコード(GHS)
| 絵表示（GHS） |
|
| 注意喚起語 |
警告 |
| 危険有害性情報 |
| コード |
危険有害性情報 |
危険有害性クラス |
区分 |
注意喚起語 |
シンボル |
P コード |
| H302 |
飲み込むと有害 |
急性毒性、経口 |
4 |
警告 |
|
P264, P270, P301+P312, P330, P501 |
|
| 注意書き |
| P280 |
保護手袋/保護衣/保護眼鏡/保護面を着用するこ と。 |
| P305+P351+P338 |
眼に入った場合：水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。 |
|
AZIMILIDE 価格
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
AZIMILIDE 化学特性,用途語,生産方法
使用
Cardiac depressant
(anti-arrhythmic).
一般的な説明
Azimilide, E-1-[[[5-(4-chlorophenyl)-2-furanyl]methylene]amino]-3-[4-(4-methyl-1-piperazinyl)butyl]-2,4-imidazolidinedione, is a class III agent that significantlyblocks the delayed rectifier potassium current,Iks, including the Ikr component. Its ability to block multichannelsmay be caused by a lack of the methane sulfonamidegroup that is common to other class III agents, whichselectively block the Ikr potassium current. It is believedthat blocking both Ikr and Iks potassium currents yields consistentclass III antiarrhythmic effects at any heart rate.
臨床応用
Azimilde is another Class III antiarrhythmic agent structurally unrelated to any of the above agents. Azimilide is not available in the United States; it is only available in Europe. Following
oral administration, the drug is completely absorbed, with no effect of food. Protein binding is 94%.
It is metabolized in the liver to an active carboxylate metabolite, but its concentration in plasma is
less than 5% of the parent compound. Thus, it is considered to be therapeutically inactive. Renal
excretion is approximately 10%. Its elimination half-life is 3 to 4 days.
酵素阻害剤
This class ΙΙΙ antiarrhythmic drug and ion channel blocker (FW = 457.95 g/mol; CAS 149908-53-2), also known by the code name NE-10064 and systematic name, 1-({(E)-[5-(4-chlorophenyl)furan-2-yl]methylidene} amino)-3-[4-(4-methylpiperazin-1-yl)butyl]-imidazolidine-2,4-dione, blocks both the slow-activating IKs and rapidly activating IKr components of the delayed rectifier potassium current, distinguishing its action from conventional potassium channel blockers such as sotalol and dofetilide,which block only IKr. Azimilide prolongs the cardiac refractory period in a dose-dependent manner, as manifested by increases in action potential duration, QTc interval, and effective refractory period.
AZIMILIDE 上流と下流の製品情報
原材料
準備製品
AZIMILIDE 生産企業
Global( 58)Suppliers
149908-53-2()キーワード:
- 149908-53-2
- AZIMILIDE
- 1-[[[5-(4-Chlorophenyl)-2-furanyl]methylene]amino]-3-[4-(4-methyl-1-piperazinyl)butyl]-2，4-imidazolidinedione
- NE-10064
- 2,4-Imidazolidinedione, 1-(((5-(4-chlorophenyl)-2-furanyl)methylene)amino)-3-(4-(4-methyl-1-piperazinyl)butyl)-
- Unii-74qu6p2934
- AZIMILIDE USP/EP/BP
- Azimilide
(NE-10064)
- 1-(((5-(4-Chlorophenyl)furan-2-yl)methylene)amino)-3-(4-(4-methylpiperazin-1-yl)butyl)imidazolidine-2,4-dione
- アジミリド